Recruiting Now in Grapevine Tx
New Psoriasis Clinical Trials in Grapevine Tx
Medically Reviewed By
Dr. Sarah Jensen, MD, Board-Certified Rheumatologist
Residents of Grapevine Tx, TX struggling with Psoriasis may qualify for a new investigational treatment study being conducted by leading Grapevine Tx facilities.
No Insurance Needed
Identify New Options
Am I Eligible?
Check if you qualify for the Up to $1,200 compensation.
Diagnosed with Psoriasis?
Aged 18-65?
Live near Grapevine Tx?
100% Free • No Insurance Required
FDA Guidelines Monitored
HIPAA Compliant Data
256-bit SSL Enrollment
Local Medical Insight
Clinical research for Psoriasis in Grapevine Tx is supported by major TX medical networks and research universities, ensuring state-of-the-art care and oversight for all participants in Grapevine Tx.
Location
The research center is conveniently located in Grapevine Tx. Validation parking is provided for all visits. (Specific address revealed upon qualification).
Qualification
- Age 18 - 65
- Diagnosed with Psoriasis
- Trying to find better management options
Available Trials in Grapevine Tx
NCT05858645(Verify on ClinicalTrials.gov)
Correction of Psoriatic T Cell Signatures by Deucravacitinib
RECRUITINGPsoriasis
NCT06242847(Verify on ClinicalTrials.gov)
Role of Insulin Action in Psoriasis Pathogenesis
RECRUITINGPsoriasis
NCT06865105(Verify on ClinicalTrials.gov)
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
RECRUITINGPsoriasis
Environmental Factors in Grapevine Tx
Living in Grapevine Tx presents unique lifestyle factors that can influence the management of Psoriasis. Local weather patterns and urban stressors are important considerations for ongoing clinical research.
Patient FAQ: Grapevine Tx
Is travel compensation available?
Yes, many trials in the area provide stipends for travel expenses.
Do I need insurance?
No, all study-related care and medication are provided at no cost.
Can I keep my current doctor?
Absolutely. Study participation is a supplemental care option.